Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Phase 2

    Forecasted

    This grant supports research using advanced single cell techniques to study how substance use disorders and HIV interact in the brain, aiming to uncover mechanisms and identify new therapy targets.

    OverviewSimilar Grants
    OverviewSimilar Grants

    High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)

    This grant aims to support innovative research on the intersection of HIV and substance use, with the goal of advancing prevention, treatment, and cure efforts among people who use drugs. It is open to both individuals and research teams, covering a wide range of research areas.

    HHS-NIH11Due Feb 5, 2027$7,500,000

    Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)

    Research grant for studying biological, behavioral, and social factors impacting HIV pathogenesis within NIDDK's mission and NIH priorities.

    HHS-NIH11Due Feb 16, 2027$275,000

    High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)

    This grant supports innovative research at the HIV and substance use intersection, focusing on new avenues for prevention, treatment, and cure among people who use drugs.

    HHS-NIH11Due Feb 3, 2027$9,000,000

    NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed)

    The NIDA Animal Genomics Program aims to identify genetic variants influencing addictive behaviors, SUD stages, associated behaviors, and comorbidities through genomics approaches.

    HHS-NIH11Due Feb 11, 2027

    Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)

    This grant funds research on drug use behaviors, prevention, and health services by analyzing existing social science, behavioral, and neuroimaging data.

    HHS-NIH11Due Nov 3, 2026· 6d